Migraine, comorbidity, and risks of severe maternal and neonatal morbidity or mortality: a population-based cohort study

• by Carmela Melina Albanese, Susan J Bondy, Christine Lay, Manav V Vyas, Zhiyin Li, Jun Guan, Hilary K Brown

• January 15, 2026

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

Board-certified neurologist Zack Z. Ramilevich, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health, as a general neurologist.

• by

• March 26, 2026

• 2 min

Evaluation of the Safety and Effectiveness of Calcitonin Gene-Related Peptide Antagonists in Treating Cluster Headaches: A Systematic Review and Meta-Analysis

• by Ro’ya Khanfar, Eithar Radwan, Sama Hattab

• February 19, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min